BMS 777607, with the CAS number 1196681-44-3, is a small molecule that functions primarily as a selective inhibitor of the protein kinase known as fibroblast growth factor receptor (FGFR). This compound has garnered attention in the field of cancer research due to its potential therapeutic applications, particularly in targeting tumors that exhibit aberrant FGFR signaling. BMS 777607 is characterized by its ability to interfere with the phosphorylation processes that are crucial for cell proliferation and survival, making it a candidate for treating various malignancies. The compound is typically studied in preclinical and clinical settings to evaluate its efficacy and safety profile. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are also of interest, as they influence the overall therapeutic potential. As with many investigational drugs, ongoing research aims to elucidate its mechanism of action, optimal dosing regimens, and potential side effects in patients.

BMS 777607

1196681-44-3: BMS 777607, with the CAS number 1196681-44-3, is a small molecule that functions primarily as a selective inhibitor of the protein kinase known as fibroblast growth factor receptor (FGFR). This compound has garnered attention in the field of cancer research due to its potential therapeutic applications, particularly in targeting tumors that exhibit aberrant FGFR signaling. BMS 777607 is characterized by its ability to interfere with the phosphorylation processes that are crucial for cell proliferation and survival, making it a candidate for treating various malignancies. The compound is typically studied in preclinical and clinical settings to evaluate its efficacy and safety profile. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are also of interest, as they influence the overall therapeutic potential. As with many investigational drugs, ongoing research aims to elucidate its mechanism of action, optimal dosing regimens, and potential side effects in patients.

BMS-777607 is a Met-related inhibitor for c-Met, Axl, Ron and Tyro3.

CAS 1196681-44-3

BMS 777607

BMS-777607

Ref: TM-T2658

BMS-777607

Ref: 54-BUP10064